-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $123

Benzinga·12/22/2025 11:39:29
語音播報
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target from $110 to $123.